| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| venBio Global Strategic Fund III, L.P. | 4.9% | $2,206,114 | 1,198,975 | venBio Global Strategic Fund III, L.P. | 31 Mar 2025 | |||
| BlackRock, Inc. | 2% | -62% | $995,740 | -$1,557,557 | 485,727 | -61% | BlackRock, Inc. | 30 Jun 2025 |
As of 30 Sep 2025, 39 institutional investors reported holding 18,152,764 shares of Artiva Biotherapeutics, Inc. - Common Stock (ARTV). This represents 75% of the company’s total 24,286,350 outstanding shares.
The largest institutional shareholders of Artiva Biotherapeutics, Inc. - Common Stock (ARTV) together control 74% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 41% | 9,853,302 | 0% | 0.35% | $28,278,977 |
| 5AM Venture Management, LLC | 9.7% | 2,353,304 | 0% | 2.5% | $6,753,982 |
| VR ADVISER, LLC | 6.6% | 1,609,569 | 0% | 0.26% | $4,619,463 |
| venBio Partners LLC | 4.7% | 1,148,975 | 0% | 1.9% | $3,297,558 |
| CITADEL ADVISORS LLC | 3.3% | 798,397 | +419% | 0% | $2,291,399 |
| FRANKLIN RESOURCES INC | 2.1% | 520,327 | 0% | 0% | $1,493,338 |
| BlackRock, Inc. | 1.2% | 294,422 | -39% | 0% | $844,992 |
| MILLENNIUM MANAGEMENT LLC | 1.1% | 262,160 | -20% | 0% | $752,399 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.8% | 194,108 | 0% | 0% | $557,090 |
| VANGUARD GROUP INC | 0.66% | 159,118 | -32% | 0% | $456,669 |
| BNP PARIBAS FINANCIAL MARKETS | 0.49% | 118,547 | 0% | 0% | $340,230 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.46% | 110,896 | -30% | 0% | $318,510 |
| CITIGROUP INC | 0.43% | 105,573 | +2860% | 0% | $302,995 |
| Alyeska Investment Group, L.P. | 0.41% | 100,000 | 0% | 0% | $287,000 |
| RENAISSANCE TECHNOLOGIES LLC | 0.33% | 79,147 | 0% | $227,152 | |
| STATE STREET CORP | 0.25% | 59,824 | -4.9% | 0% | $171,695 |
| GOLDMAN SACHS GROUP INC | 0.2% | 49,777 | -58% | 0% | $142,860 |
| XTX Topco Ltd | 0.2% | 47,973 | 0.01% | $137,683 | |
| MORGAN STANLEY | 0.18% | 42,829 | -7.4% | 0% | $122,919 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 0.16% | 39,133 | 0.01% | $112,311 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.14% | 35,000 | 0% | 0% | $100,450 |
| HRT FINANCIAL LP | 0.11% | 26,953 | -65% | 0% | $77,000 |
| Qube Research & Technologies Ltd | 0.11% | 25,552 | -34% | 0% | $73,334 |
| UBS Group AG | 0.09% | 21,143 | +534% | 0% | $60,680 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | 20,364 | -4.7% | 0% | $58,445 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 18,152,764 | $52,098,905 | -$149,494 | $2.87 | 39 |
| 2025 Q2 | 18,507,398 | $27,946,001 | -$5,466,427 | $1.51 | 47 |
| 2025 Q1 | 20,919,533 | $62,758,590 | -$3,180,577 | $3.00 | 52 |
| 2024 Q4 | 21,161,524 | $213,250,346 | +$4,529,241 | $10.08 | 57 |
| 2024 Q3 | 20,699,707 | $318,929,124 | +$305,945,387 | $15.45 | 48 |